SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BREVEGLIERI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.494
AS - Asia 6.229
EU - Europa 4.061
SA - Sud America 1.004
AF - Africa 157
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 20.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.267
SG - Singapore 2.209
CN - Cina 1.835
IT - Italia 865
PL - Polonia 863
BR - Brasile 806
VN - Vietnam 673
DE - Germania 521
HK - Hong Kong 480
UA - Ucraina 441
GB - Regno Unito 329
TR - Turchia 267
FR - Francia 234
FI - Finlandia 214
SE - Svezia 195
JP - Giappone 160
RU - Federazione Russa 137
IN - India 135
CA - Canada 109
ID - Indonesia 102
MX - Messico 83
NL - Olanda 72
AR - Argentina 70
BD - Bangladesh 62
ZA - Sudafrica 52
IQ - Iraq 37
IR - Iran 35
PK - Pakistan 35
BE - Belgio 34
ES - Italia 34
EC - Ecuador 31
CO - Colombia 28
VE - Venezuela 27
UZ - Uzbekistan 25
MA - Marocco 23
KR - Corea 21
LT - Lituania 20
CZ - Repubblica Ceca 19
AU - Australia 18
MY - Malesia 18
PH - Filippine 18
TN - Tunisia 17
KE - Kenya 15
EG - Egitto 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
PY - Paraguay 11
AT - Austria 9
AZ - Azerbaigian 9
CH - Svizzera 9
DZ - Algeria 9
ET - Etiopia 9
PE - Perù 9
RO - Romania 9
NP - Nepal 8
PT - Portogallo 8
TW - Taiwan 8
IE - Irlanda 7
JO - Giordania 7
BG - Bulgaria 6
KZ - Kazakistan 6
LB - Libano 6
PA - Panama 6
TH - Thailandia 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
GR - Grecia 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
UY - Uruguay 5
CR - Costa Rica 4
GE - Georgia 4
IL - Israele 4
JM - Giamaica 4
PS - Palestinian Territory 4
RS - Serbia 4
YE - Yemen 4
EE - Estonia 3
KW - Kuwait 3
NI - Nicaragua 3
OM - Oman 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
LY - Libia 2
ML - Mali 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
Totale 20.939
Salva come PNG Salva come JPEG
Città #
Singapore 1.398
Ashburn 1.144
Warsaw 849
Woodbridge 698
Beijing 691
San Jose 579
Fairfield 558
Chandler 557
Houston 495
Ann Arbor 492
Jacksonville 485
Hong Kong 466
Santa Clara 416
Ferrara 283
Wilmington 274
Seattle 241
Ho Chi Minh City 226
Dallas 211
Nanjing 184
Cambridge 167
Hanoi 166
New York 161
Tokyo 149
Izmir 146
Los Angeles 142
Bologna 118
Princeton 116
Munich 109
Lauterbourg 102
Boardman 89
Addison 84
Council Bluffs 82
Milan 79
Shanghai 78
Jakarta 68
Helsinki 65
Orem 59
Shenyang 58
Bremen 55
San Diego 54
São Paulo 53
Mexico City 50
Redwood City 48
Nanchang 46
London 42
Turku 42
Brooklyn 41
Chennai 40
Montreal 37
Da Nang 36
Falls Church 36
Hebei 35
Rio de Janeiro 35
Denver 33
Frankfurt am Main 33
Hefei 33
Haiphong 32
Moscow 32
Stockholm 32
Dearborn 31
Guangzhou 31
Hangzhou 30
Brussels 29
Johannesburg 29
Toronto 29
Zhengzhou 29
Changsha 28
Manchester 27
Tianjin 27
Auburn Hills 24
Jiaxing 23
San Francisco 23
Poplar 22
Tashkent 22
The Dalles 22
Mountain View 21
Brasília 20
Buffalo 20
Chicago 20
Curitiba 20
Verona 20
Atlanta 19
Dong Ket 19
Guayaquil 19
Rome 19
Nuremberg 17
Phoenix 17
Amsterdam 16
Norwalk 16
Baghdad 15
Jinan 15
Ningbo 15
Belo Horizonte 14
Boston 14
Columbus 14
Mumbai 14
Orange 14
Ankara 13
Brno 13
Ferrara di Monte Baldo 13
Totale 13.973
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 413
A validated cellular biobank for β-thalassemia 411
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 375
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 371
A validated THALAMOSS cellular biobank for β-thalassemia 329
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 295
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 294
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 289
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 271
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 270
SPR-based non-invasive prenatal testing for fetal sex determination 250
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 241
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 233
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 230
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 224
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 223
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 221
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 220
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 219
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 219
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 218
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 218
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 217
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 214
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 211
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 210
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 208
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 199
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 197
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 191
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 189
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 188
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 187
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 185
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 185
Alteration of microRNA biological activity with peptide nucleic acid 184
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 183
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 183
Cellular biosensors for the identification of fetal hemoglobin inducers 182
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 182
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 182
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 179
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 179
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 177
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 176
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 172
Development and molecular characterization of transgenic mice for beta-thalassemia 170
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 169
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 167
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 166
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 162
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 161
Gene therapy combined with HbF induction in beta-thalassemia 156
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 153
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 152
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR 150
Gene therapy and fetal hemoglobin induction 149
Targeting the miR-221/miR-222 cluster in cancer therapy 148
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 146
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 145
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 145
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 145
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 144
Evidences for miRNA regulation of BCL11A gene expression 143
Non-invasive Prenatal Testing Using Fetal DNA 142
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 141
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 141
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of β°39 thalassemia mutation 140
IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo 135
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 135
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 133
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 133
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 130
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 130
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 130
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 130
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 129
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 128
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 128
Detection of disorders in unamplified human genomic DNA 127
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 126
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 124
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 123
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 121
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 121
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 120
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 119
PNA-mediated alteration of mRNA splicing 118
SPR-based identification of microRNAs 117
null 117
Induction of high levels of apoptosis of temozolomide-resistant T98G glioma cells by co-administration of peptide nucleic acids targeting miR-221 and miR-222 116
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 113
Production of a cellular model for the screening of inducers of fetal haemoglobin 112
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 111
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 110
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 109
Peptide nucleic acids targeting miR-221 in human gliomas: uptake and modulation of miR-221 biological functions 108
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 108
Inhibition of micro RNA 221 biological activity with an anti-miR-221 peptide nucleic acid 107
null 107
Totale 17.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.626
Totale 87.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021679 0 0 0 0 0 0 0 0 0 223 302 154
2021/20221.223 139 103 33 40 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024808 50 107 35 31 64 156 82 42 11 16 52 162
2024/20252.965 80 70 230 154 305 246 127 144 511 327 391 380
2025/20267.801 818 318 670 1.012 1.252 562 1.020 534 789 826 0 0
Totale 21.262